Stop me if you’ve heard this one before. The DOJ has charged a publicly traded Silicon Valley med tech firm and its CEO with touting a sham finger stick blood test to defraud payors and rip off investors. No, the company is not Theranos, and the executive is not Elizabeth Holmes. But while the dimensions…

This content is for Paid Members only.
Login Register